D2 vs D3 Lymph Node Dissection for Left Colon Cancer

Recruiting now · Not applicable

Conditions studied: Colon Cancer

In brief

The efficiency of the D3 lymph node dissection is still controversial for left colon cancer patients. This study will try find difference in 5-year overall survival between D2 and D3 lymph node dissection. Investigation of the functional and short-term outcomes will clarify safety of the D3 lymph node dissection.

Key facts

Study ID

NCT04364373

Run by

Russian Society of Colorectal Surgeons

People needed

1381

Starts

2020-03-31

Expected to finish

2033-12-31

Last updated by the study team

2024-04-09

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Agreement of the patient to participate in trial
• Colon cancer (only adenocarcinoma )
• The tumor located between the splenic flexure and rectosigmoid junction
• cT3-Т4а,b
• cN0-2
• cM0
• Tolerance of chemotherapy
• ASA 1-3

You may not qualify if…

• сТis - Т2, сТ4b (tail of the pancreas, stomach, small bowel, ureter, urinary bladder)
• Preoperative complications of the tumor (perforation and full bowel 3. obstruction)
• Previous radiotherapy or chemotherapy
• Synchronous or metachronous tumors
• Women during Pregnancy or breast feeding period

Where it is running

• Clinic of coloproctology and minimally invasive surgery — Moscow, Russia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.